期刊文献+

唑来膦酸对成骨细胞单核巨噬细胞共培养体系中Atp6v0d2基因表达及破骨细胞生成的抑制作用 被引量:5

The inhibition of Atp6v0d2 gene expression and osteoclastogenesis by zoledronate acid in a mononuclear phagocyte-osteoblast co-culture system
下载PDF
导出
摘要 目的:研究唑来膦酸(ZOL)对破骨细胞(OC)生成的影响,探讨Atp6v0d2基因在其中发挥的作用。方法:应用小鼠颅骨成骨细胞(OB)与小鼠单核巨噬细胞RAW264.7建立共培养体系。细胞分为对照组和ZOL处理组(ZOL处理24 h)。在不同时间点收获细胞,检测Atp6v0d2基因表达、OC生成和骨吸收情况。结果:ZOL组TRAP染色阳性多核OC和骨吸收陷窝显著少于对照组(P<0.01);Atp6v0d2基因表达在ZOL组显著下降(P<0.01)。结论:ZOL可显著抑制OB与RAW264.7共培养体系中OC生成和骨吸收功能,下调Atp6v0d2基因表达。 Objective:To study the effect of zoledronate(ZOL) on Atp6v0d2 gene expression and osteoclastogenesis.Methods:Mouse calvarial osteoblasts(OB) and mouse mononuclear phagocyte RAW264.7 cells were used to establish a co-culture system.In ZOL group the cells were treated by ZOL for 24 h,while in control group the cells were cultured without ZOL.The cells were harvested at different time points and gene expression of Atp6v0d2,osteoclastogenesis and bone resorption were examined.Results:The number and size of TRAP positive multi-nucleated cells and absorption lacunae were all significantly decreased in ZOL group when compared with the controls (P < 0.01).Atp6v0d2 gene expression was down-regulated in ZOL group (P < 0.01).Conclusion:In the OB-RAW264.7 co-culture system,ZOL may inhibit Atp6v0d2 expression and osteoclast formation.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2013年第6期766-769,共4页 Journal of Practical Stomatology
基金 国家自然科学基金(编号:81270965) 河北省自然科学基金(编号:C2011401044)
关键词 唑来膦酸 破骨细胞生成 空泡型质子泵ATPase V0 d2亚基 抗酒石酸酸性磷酸酶 Zoledronate Osteoclastogenesis Vacuolar-ATPases V0d2 Tartrate-resistant acid phosphatase
  • 相关文献

参考文献12

  • 1Edwards JR, Weivoda MM. Osteoclasts: Malefactors of dis- ease and targets for treatment [ J ]. Discov Med, 2012, 13 (70) :201 -210.
  • 2Kim T, Ha HI, Kim N, et al. Adrml interacts with Atp6v0d2 and regulates osteoclast differentiation [ J]. Bio- chem Biophys Res Commun, 2009, 390(3) :585 -590.
  • 3Wu H, Xu G, Li YP. Atp6v0d2 is an essential component of the osteoclast - specific proton pump that mediates extra- cellular acidification in bone resorption [ J ]. J Bone Miner Res, 2009, 24(5):871 -885.
  • 4Piper PK Jr, Gruntmanis U. Management of osteoporosis in the aging male: Focus on zoledronic acid [ J ]. Clin Interv Aging, 2009, 4:289-303.
  • 5董伟,戚孟春,梁永强,温黎明,冯晓洁,李任.共培养体系中阿仑膦酸钠对破骨细胞相关基因表达的影响[J].实用口腔医学杂志,2012,28(6):682-685. 被引量:2
  • 6刘强,董伟,戚孟春,邓久鹏,梁永强,冯晓洁,李金源.阿仑膦酸盐对破骨细胞生成的抑制及钙离子激动剂的拮抗效应[J].实用口腔医学杂志,2012,28(2):182-186. 被引量:7
  • 7戚孟春,胡静,邹淑娟,韩力赤,罗恩.大鼠骨髓间充质干细胞和颅骨成骨细胞在张应力下细胞骨架的改变[J].华西口腔医学杂志,2005,23(2):110-112. 被引量:24
  • 8Kim K, Lee SH, Ha Kim J, et al. NFATcl induces osteo- clast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP) [ J]. Mol Endocrinol, 2008, 22 ( 1 ) : 176 - 185.
  • 9Zhang Z, Zheng Y, Mazon H, et al. Structure of the yeast vacuolar ATPase [ J ]. J Bid Chem, 2008, 283 (51 ) : 35983 - 35995.
  • 10Cipriano D J, Wang Y, Bond S, et al. Structure and regula- tion of the vacuolar ATPases [ J ]. Biochim Biophys Acta, 2008, 1777 (7 - 8) :599 - 604.

二级参考文献33

  • 1戚孟春,胡静,邹淑娟,韩力赤,罗恩.大鼠骨髓间充质干细胞和颅骨成骨细胞在张应力下细胞骨架的改变[J].华西口腔医学杂志,2005,23(2):110-112. 被引量:24
  • 2徐琳,谭颖徽,何海涛.降钙素基因相关肽对兔成骨细胞OPG/RANKLmRNA表达的影响[J].实用口腔医学杂志,2005,21(3):396-399. 被引量:14
  • 3赵玉明,葛立宏,A E Grigoriadis.转化生长因子β对体外破骨细胞分化的影响[J].实用口腔医学杂志,2006,22(1):38-40. 被引量:8
  • 4Zhang J,Ding X,Bian Z,et al.The effect of anti-eppinantibodies on ionophore A23187-induced calcium influx andacrosome reaction of human spermatozoa[J].Hum Reprod,2010,25(1):29-36.
  • 5Coxon FP,Thompson K,Rogers MJ.Recent advances inunderstanding the mechanism of action of bisphosphonates[J].Curr Opin Pharmacol,2006,6(3):307-312.
  • 6Kwak HB,Kim JY,Kim KJ,et al.Risedronate directly in-hibits osteoclast differentiation and inflammatory bone loss[J].Biol Pharm Bull,2009,32(7):1193-1198.
  • 7Glantschnig H,Fisher JE,Wesolowski G,et al.M-CSF,TNFαand RANK ligand promote osteoclast survival by sig-naling through mTOR/S6 kinase[J].Cell Death Differ,2003,10(10):1165-1177.
  • 8Ishida N,Hayashi K,Hoshijima M,et al.Large scale geneexpression analysis of osteoclastogenesis in vitro and elucida-tion of NFAT2 as a key regulator[J].J Biol Chem,2002,277(43):41147-41156.
  • 9Asagiri M,Sato K,Usami T,et al.Autoamplification ofNFATc1 expression determines its essential role in bone ho-meostasis[J].J Exp Med,2005,202(9):1261-1269.
  • 10Grigoriadis AE,Wang ZQ,Cecchini MG,et al.c-Fos:Akey regulator of osteoclast-macrophage lineage determinationand bone remodeling[J].Science,1994,266(5184):443-448.

共引文献30

同被引文献111

  • 1张大威,程岩,张金超,王乃利,杨梦甦,姚新生.淫羊藿苷对破骨细胞的分化及骨吸收功能的影响[J].中国药理学通报,2007,23(4):463-467. 被引量:73
  • 2Maeda SS, Lazaretti-Castro M. An overview on the treatment of postmenopausal osteoporosis. Arq Bras Endocrinol Metabol. 2014;58(2):162-171.
  • 3Costa AG, Cusano NE, Silva BC, et al. Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat Rev Rheumatol. 2011 ;7(8):447-456.
  • 4Kwak HB, Kim JY, Kim K J, et al. Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol Pharm Bull. 2009;32(7):1193-1198.
  • 5Pang M, Martinez AF, Fernandez I, et al. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells. Gene. 2004(1-2): 151-158.
  • 6Arai M, Nagasawa T, Koshihara Y, et al. Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochem Biophys Acta. 2003;1640: 137-142.
  • 7Leung P, Pickarski M, Zhuo Y, et al. The effects Of the cethepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. Bone. 2011 ;49(4):623-635.
  • 8Troen BR. The regulation of cathepsin K gene expression. Ann N YAcad Sci. 2006,1068:165-172.
  • 9Li Z, Hou WS, Escalante-Torres CR, et al. Collagenase activity of cathepsin k depends on complex fromation with chordroitin sulfate. J Biol Chem. 2002:277:28669-28876.
  • 10Wilson SR, Peters C,Saftig P, et aI.Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption. J Biol Chem. 2009;284(4): 2584-2592.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部